首页> 外国专利> CELL AND TRANSGENIC ANIMAL MODELLING HUMAN ANTIGENIC PRESENTATION AND THEIR USES

CELL AND TRANSGENIC ANIMAL MODELLING HUMAN ANTIGENIC PRESENTATION AND THEIR USES

机译:细胞和转基因动物模型的人类抗原表达及其用途

摘要

An isolated animal cell containing at least one transgene having a sequence encoding part or all of a human polypeptide implicated in the antigenic recognition and/or cellular activity of T cells, is new. An isolated animal cell containing at least one transgene having a sequence encoding part or all of a human polypeptide implicated in the antigenic recognition and/or cellular activity of T cells, where the transgene is stably inserted into the genome by targeted homologue recombination ('Knock In') to at least one allele of an endogenous gene so that the gene is invalidated. Independent claims are also included for: (1) a non-human transgenic animal comprising the claimed cell; and (2) detecting a compound which modulates the human immune system, comprising contacting the claimed cell or transgenic animal with an immunogen responsible for releasing an immune response, and a test compound, and quantitatively or qualitatively determining the response.
机译:含有至少一个转基因的分离的动物细胞是新的,该转基因具有编码涉及T细胞的抗原识别和/或细胞活性的部分或全部人类多肽的序列。分离的动物细胞,其包含至少一个转基因,所述转基因具有编码涉及T细胞的抗原识别和/或细胞活性的部分或全部人类多肽的序列,其中所述转基因通过靶向同源重组稳定地插入基因组中('Knock In')至内源基因的至少一个等位基因,从而使该基因无效。还包括以下方面的独立权利要求:(1)包含要求保护的细胞的非人转基因动物; (2)检测调节人类免疫系统的化合物,包括使所要求保护的细胞或转基因动物与负责释放免疫应答的免疫原和测试化合物接触,并定量或定性确定该应答。

著录项

  • 公开/公告号EP1414949A1

    专利类型

  • 公开/公告日2004-05-06

    原文格式PDF

  • 申请/专利权人 GENOWAY;

    申请/专利号EP20020784869

  • 申请日2002-07-12

  • 分类号C12N5/10;A01K67/027;G01N33/50;A61K35/14;A61K48/00;

  • 国家 EP

  • 入库时间 2022-08-21 22:52:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号